Navigation Links
Ralphs Introduces $4 Generic Drugs
Date:4/4/2008

Starts Friday, April 4 at Ralphs Pharmacies Throughout Southern California

LOS ANGELES, April 4, 2008 /PRNewswire/ -- Starting today, Ralphs will begin offering pharmacy customers generic drugs for $4 per prescription at its stores in Southern California.

The $4 price will apply to hundreds of generic drugs prescribed for 30-day supplies and will be available at 90 pharmacies in Ralphs stores throughout Southern California. A list of the participating pharmacies and eligible generic drugs is available at http://www.ralphs.com/generic or by calling 1-877-4RX-LIST (1-877-479-5478).

Ralphs' program includes generic alternatives for some of the most commonly prescribed drugs used to treat conditions such as diabetes, asthma, depression, heart disease, thyroid and other health problems.

"We're pleased to offer Ralphs customers an affordable alternative to meet their health and medication needs," said Mike Donnelly, President of Ralphs. "Our customers can take advantage of low prices on generic drugs while continuing to rely on the expert, professional counsel of our pharmacists."

Customers interested in these low-price generic drugs should consult their doctor or Ralphs pharmacist to determine if a generic drug is available for their prescription and is right for them. These $4 prescriptions are available in Ralphs pharmacies and for on-line and telephone orders for customers to pick up in a store.

"People wanting to take advantage of our generic drug program can easily make arrangements to transfer their prescriptions by calling participating Ralphs pharmacies," Mr. Donnelly said.

Separately, Ralphs will offer generic versions of the family planning drugs Ortho Cyclen(R) and Ortho Tri Cyclen(R) (28-day supply) and a fertility drug for $9.

About Generic Drugs

Generic drugs are as safe and effective as brand name drugs (according to federal law, the
'/>"/>

SOURCE Ralphs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ralphs Pink Tag Campaign to Raise $170,000 for Breast Cancer Awareness in October
2. AMBI(R) Introduces SOFT & EVEN(TM)
3. Dynatronics Introduces New Synergie Elite Aesthetic Line
4. Kinetic Technologies, Makers of Conquer(R), Introduces New Website
5. CryoCath Introduces Arctic Front in Australia
6. SOYJOY(R) Introduces Two New Ways to Enjoy Soy
7. Toms of Maine Introduces a Patent-Pending New Formula with the Launch of its Natural Clean & Gentle Care and Sensitive Care Toothpastes
8. Blue Cross of California Introduces Pay-for-Performance Hospital Program
9. Schiff(R) Introduces New Supplement Products for Intestinal Health and Beauty Maintenance
10. Quaker Introduces Simple Harvest(TM) All Natural Multigrain Chewy Granola Bars That Taste Simply Delicious
11. Wildwood Organics Introduces Probiotic Soymilk(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2015)... ... 2015 , ... Doctors in Chicago have published a new study on the ... Mesothelioma has just posted an article on the research on its website. Click ... performed a retrospective analysis of 117 mesothelioma patients who underwent extended pleurectomy between 2008 ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published ... for in nursing homes and assisted living facilities are receiving insufficient care that could ... which her father was at one point close to death, not because of a ...
(Date:9/4/2015)... ... , ... Mile High Connects today releases “First and Last Mile Connections,” a ... bike paths, and other vital supports severely limit access to public transportation for many ... to expand public transit, there’s very little support for safe and convenient access to ...
(Date:9/4/2015)... ... 04, 2015 , ... After wearing the same uniforms for six seasons, the ... an effort to assist the team, the Jones Agency, a locally owned insurance firm ... funds for the new uniforms. , As is so often the case with high ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... now available at CitiDent. CEREC is a newer method for creating restorations through ... for patients by eliminating the need for multiple appointments, CEREC produces restorations with ...
Breaking Medicine News(10 mins):Health News:New Study Appears to Validate the Safety of Mesothelioma Surgery for Older Patients, According to Surviving Mesothelioma 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... Protect World,s Supply of Donated Blood from ... Expansion into New Global Markets and Development ... Instrument- Companies Also Plan Exploratory Collaboration in ... Including Additional Revenue and Profit from AgreementSAN ...
... to $765.3 Million; Positive Operating Cash Flow Targeted By ... Pharmaceuticals, Inc. (Nasdaq: AMLN ) today reported ... 31, 2008. The Company reported total revenue of $202.5 ... includes net product sales of $184.9 million. Net loss, ...
... Obama and Republican Actions Run Counter to Public ... to strip funding for family planning from President ... pledges to support the programs and their high ... poll of voters, done for the Women Donors ...
... leads to similar survival rates in older patients , , ... molecule known as brain natriuretic peptide (BNP) to guide ... not improve the clinical outcome in most cases in ... about the value of monitoring blood levels of BNP, ...
... 27 Omnicell, Inc.,(Nasdaq: OMCL ) a leading ... a five year contract by Duke University Health,System ... Duke University Health System is ... Raleigh Hospital, and many other clinical,facilities. , ...
... An evaluation of 203 women as part of the ... who transitioned more quickly through menopause were at increased ... atherosclerosis" narrowing of arteries caused by the thickening ... M.D., is principal investigator of the study. She is ...
Cached Medicine News:Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 2Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 3Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 4Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 5Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 2Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 3Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 4Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 5Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 6Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 7Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 8Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 9Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 10Health News:Family Planning Again Becomes Political Football 2Health News:Family Planning Again Becomes Political Football 3Health News:Monitoring Protein Didn't Improve Heart Failure Outcomes 2Health News:Monitoring Protein Didn't Improve Heart Failure Outcomes 3Health News:Omnicell is Awarded Contract by Major National Academic Medical Center 2Health News:Is rapid transition through menopause linked to earlier onset of heart disease? 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
... The ESR-10 Manual Rack is a ... determining the erythrocyte sedimentation rate (ESR) ... using 1.2ml Streck ESR-Vacuum Tubes. The ... tubes simultaneously. The ESR-10 Manual Rack ...
... Streck Cytometry Concentrate is for use as ... flow cytometry. Each 70ml bottle of Cytometry ... with distilled water. Compared to Cubitainers, Streck ... space and saves money without compromising performance. ...
Medicine Products: